Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 11, 2016 09:03 ET | Source: Abeona Therapeutics

Abeona Therapeutics Announces Initial European Regulatory Approvals for Phase 1/2 Gene Therapy Clinical Studies for Patients With Sanfilippo Syndromes Type A (MPS IIIA) and Type B (MPS IIIB)

NEW YORK, NY, and CLEVELAND, OH--(Marketwired - January 11, 2016) - Approval of Genetically Modified Organism (GMO) and Ethical Committee (CEIC) regulatory filings for both ABO-101...
December 01, 2015 09:03 ET | Source: Abeona Therapeutics

Abeona Therapeutics to Present at Piper Jaffray 27th Annual Healthcare Conference

NEW YORK, NY--(Marketwired - December 01, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for...
November 18, 2015 09:03 ET | Source: Abeona Therapeutics

Abeona Therapeutics to Present at Jefferies 2015 Global Healthcare Conference

NEW YORK, NY--(Marketwired - November 18, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for...
November 17, 2015 09:03 ET | Source: Abeona Therapeutics

Abeona Therapeutics Reports Financial Results and Highlights for Third Quarter 2015

NEW YORK, NY and CLEVELAND, OH--(Marketwired - November 17, 2015) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and...
October 06, 2015 09:03 ET | Source: Abeona Therapeutics Inc.

Abeona Therapeutics Announces License for Next Generation AAV Delivery Vector for Fanconi Anemia and Rare Blood Disease Platform

NEW YORK, NY--(Marketwired - October 06, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO)License enables lead CRISPR/Cas9 program for ABO-301 (AAV-FANCC) for Fanconi anemia and rare blood disorder...
October 01, 2015 16:04 ET | Source: Abeona Therapeutics Inc.

Abeona Therapeutics to Present at 2015 Stem Cell Meeting on the Mesa

NEW YORK, NY--(Marketwired - October 01, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for...
September 03, 2015 09:03 ET | Source: Abeona Therapeutics

Abeona Therapeutics to Present at 2015 Rodman & Renshaw Annual Global Investment Conference

NEW YORK, NY--(Marketwired - September 03, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for...
August 24, 2015 09:03 ET | Source: Abeona Therapeutics

Abeona Therapeutics to Present at the 2015 Sidoti Emerging Growth Conference

NEW YORK, NY--(Marketwired - August 24, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for...
August 17, 2015 09:03 ET | Source: Abeona Therapeutics Inc.

Abeona Therapeutics Announces Recent Highlights and Second Quarter 2015 Conference Call

NEW YORK, NY--(Marketwired - August 17, 2015) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for...
August 03, 2015 09:03 ET | Source: Abeona Therapeutics Inc

Abeona Therapeutics Announces Closing of Upsized $15.5 Million Equity Financing With Institutional Investors and Management

NEW YORK, NY--(Marketwired - August 03, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for...